BDX
Price
$191.25
Change
-$1.08 (-0.56%)
Updated
Nov 19, 04:59 PM (EDT)
Capitalization
54.81B
70 days until earnings call
Intraday BUY SELL Signals
PDEX
Price
$28.99
Change
-$1.35 (-4.45%)
Updated
Nov 19, 04:59 PM (EDT)
Capitalization
94.3M
70 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

BDX vs PDEX

Header iconBDX vs PDEX Comparison
Open Charts BDX vs PDEXBanner chart's image
Becton Dickinson and
Price$191.25
Change-$1.08 (-0.56%)
Volume$12.5K
Capitalization54.81B
Pro-Dex
Price$28.99
Change-$1.35 (-4.45%)
Volume$200
Capitalization94.3M
BDX vs PDEX Comparison Chart in %
BDX
Daily Signal:
Gain/Loss:
PDEX
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
BDX vs. PDEX commentary
Nov 20, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BDX is a Hold and PDEX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 20, 2025
Stock price -- (BDX: $191.22 vs. PDEX: $28.91)
Brand notoriety: BDX and PDEX are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: BDX: 79% vs. PDEX: 57%
Market capitalization -- BDX: $54.81B vs. PDEX: $94.3M
BDX [@Pharmaceuticals: Other] is valued at $54.81B. PDEX’s [@Pharmaceuticals: Other] market capitalization is $94.3M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $200.16B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $11.71B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BDX’s FA Score shows that 1 FA rating(s) are green whilePDEX’s FA Score has 1 green FA rating(s).

  • BDX’s FA Score: 1 green, 4 red.
  • PDEX’s FA Score: 1 green, 4 red.
According to our system of comparison, both BDX and PDEX are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BDX’s TA Score shows that 5 TA indicator(s) are bullish while PDEX’s TA Score has 4 bullish TA indicator(s).

  • BDX’s TA Score: 5 bullish, 5 bearish.
  • PDEX’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, BDX is a better buy in the short-term than PDEX.

Price Growth

BDX (@Pharmaceuticals: Other) experienced а -0.47% price change this week, while PDEX (@Pharmaceuticals: Other) price change was -10.99% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -2.03%. For the same industry, the average monthly price growth was -0.29%, and the average quarterly price growth was +8.18%.

Reported Earning Dates

BDX is expected to report earnings on Jan 29, 2026.

PDEX is expected to report earnings on Jan 29, 2026.

Industries' Descriptions

@Pharmaceuticals: Other (-2.03% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BDX($54.8B) has a higher market cap than PDEX($94.3M). BDX has higher P/E ratio than PDEX: BDX (32.86) vs PDEX (8.71). BDX YTD gains are higher at: -14.356 vs. PDEX (-38.160). BDX has higher annual earnings (EBITDA): 4.92B vs. PDEX (17.1M). PDEX has less debt than BDX: PDEX (13.8M) vs BDX (19.3B). BDX has higher revenues than PDEX: BDX (21.4B) vs PDEX (70.2M).
BDXPDEXBDX / PDEX
Capitalization54.8B94.3M58,112%
EBITDA4.92B17.1M28,754%
Gain YTD-14.356-38.16038%
P/E Ratio32.868.71377%
Revenue21.4B70.2M30,484%
Total CashN/A10.6M-
Total Debt19.3B13.8M139,855%
FUNDAMENTALS RATINGS
BDX vs PDEX: Fundamental Ratings
BDX
PDEX
OUTLOOK RATING
1..100
1316
VALUATION
overvalued / fair valued / undervalued
1..100
21
Undervalued
64
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
7831
PRICE GROWTH RATING
1..100
5663
P/E GROWTH RATING
1..100
5698
SEASONALITY SCORE
1..100
6550

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

BDX's Valuation (21) in the Medical Specialties industry is somewhat better than the same rating for PDEX (64) in the Medical Or Nursing Services industry. This means that BDX’s stock grew somewhat faster than PDEX’s over the last 12 months.

BDX's Profit vs Risk Rating (100) in the Medical Specialties industry is in the same range as PDEX (100) in the Medical Or Nursing Services industry. This means that BDX’s stock grew similarly to PDEX’s over the last 12 months.

PDEX's SMR Rating (31) in the Medical Or Nursing Services industry is somewhat better than the same rating for BDX (78) in the Medical Specialties industry. This means that PDEX’s stock grew somewhat faster than BDX’s over the last 12 months.

BDX's Price Growth Rating (56) in the Medical Specialties industry is in the same range as PDEX (63) in the Medical Or Nursing Services industry. This means that BDX’s stock grew similarly to PDEX’s over the last 12 months.

BDX's P/E Growth Rating (56) in the Medical Specialties industry is somewhat better than the same rating for PDEX (98) in the Medical Or Nursing Services industry. This means that BDX’s stock grew somewhat faster than PDEX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BDXPDEX
RSI
ODDS (%)
Bullish Trend 2 days ago
55%
Bearish Trend 2 days ago
86%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
50%
Bullish Trend 2 days ago
76%
Momentum
ODDS (%)
Bullish Trend 2 days ago
47%
Bearish Trend 2 days ago
79%
MACD
ODDS (%)
Bullish Trend 2 days ago
45%
Bearish Trend 2 days ago
80%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
44%
Bearish Trend 2 days ago
76%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
43%
Bullish Trend 2 days ago
74%
Advances
ODDS (%)
Bullish Trend 7 days ago
43%
Bullish Trend 9 days ago
79%
Declines
ODDS (%)
Bearish Trend 17 days ago
38%
Bearish Trend 2 days ago
75%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
59%
Bearish Trend 2 days ago
86%
Aroon
ODDS (%)
Bearish Trend 2 days ago
39%
Bullish Trend 2 days ago
86%
View a ticker or compare two or three
Interact to see
Advertisement
BDX
Daily Signal:
Gain/Loss:
PDEX
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
GAEM26.630.01
+0.05%
Simplify Gamma Emerging Market Bond ETF
UST44.41-0.02
-0.04%
ProShares Ultra 7-10 Year Treasury
EMMF31.10-0.02
-0.06%
WisdomTree Emerging Markets Mltfctr
FEPI45.16-0.18
-0.40%
REX FANG & Innovation Equity Prm Inc ETF
FDN262.81-1.49
-0.56%
First Trust Dow Jones Internet ETF

PDEX and

Correlation & Price change

A.I.dvisor indicates that over the last year, PDEX has been loosely correlated with LMAT. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if PDEX jumps, then LMAT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PDEX
1D Price
Change %
PDEX100%
-4.71%
LMAT - PDEX
34%
Loosely correlated
+0.54%
LDXHF - PDEX
25%
Poorly correlated
-13.33%
TCMD - PDEX
24%
Poorly correlated
+4.48%
PRE - PDEX
23%
Poorly correlated
+3.21%
BDX - PDEX
23%
Poorly correlated
-0.58%
More